Physician profile
Norma Rowello
NPI 1144877663
$983.49
in general payments reported to CMS, 2019-2025
17 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.10 · 2022: $37.64 · 2023: $220 · 2024: $368 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $255.46 | 2024-2025 | Artegraft Vascular Graft |
| Baxter Healthcare | $190.38 | 2023-2025 | Floseal, Perclot |
| Amgen INC. | $121.02 | 2024 | |
| Veloxis Pharmaceuticals, INC. | $52.01 | 2023-2025 | Envarsus |
| One Lambda, INC. | $49.59 | 2025 | |
| Vifor Pharma, INC. | $48.95 | 2023-2025 | Veltassa |
| Ani Pharmaceuticals, INC. | $45.16 | 2022-2023 | Purified Cortrophin Gel |
| Pharmacyclics LLC, An Abbvie Company | $42.41 | 2021 | |
| Novartis Pharmaceuticals Corporation | $29.78 | 2025 | |
| Mallinckrodt Hospital Products INC. | $29.67 | 2025 | Acthar |
| Acera Surgical, INC. | $23.24 | 2025 | Restrata Wound Matrix |
| Solventum Corporation | $23.16 | 2025 | Prevena, V.A.C. Veraflo |
| Kci USA, INC. | $15.15 | 2022 | |
| Merck Sharp & Dohme LLC | $14.82 | 2024 | Prevymis |
| Glaxosmithkline, LLC. | $14.28 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emmaus Medical, INC. | $14.23 | 2021 | |
| Eisai INC. | $14.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norma Rowello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.